Table 1.
Clinical and pathological characterization of breast cancer patients participating in the study.
| Clinical-pathological characteristics | All cases (118) Ductal breast cancer |
% | Groups according to metastasis | |||
|---|---|---|---|---|---|---|
| N0 | N1 | |||||
| Cases (54) |
% | Cases (64) |
% | |||
| Age (years) | ||||||
| ≤55 | 77 | 65 | 32 | 60 | 45 | 70 |
| >55 | 41 | 35 | 22 | 40 | 19 | 30 |
| Tumor size | ||||||
| T1 (<2 cm) | 25 | 21 | 13 | 24 | 12 | 19 |
| T2 (2–5 cm) | 79 | 67 | 35 | 65 | 44 | 69 |
| T3 (>5 cm) | 14 | 12 | 6 | 11 | 8 | 12 |
| Tumor grade (SBR) | ||||||
| I | 29 | 25 | 17 | 31 | 12 | 19 |
| II | 65 | 55 | 29 | 54 | 36 | 56 |
| III | 24 | 20 | 8 | 15 | 16 | 25 |
| Nodal status | ||||||
| pN0 | 54 | 46 | 54 | 100 | ||
| pN1 | 30 | 25 | 30 | 47 | ||
| pN2 | 28 | 24 | 28 | 44 | ||
| pN3 | 6 | 5 | 6 | 9 | ||
| Mononuclear infiltrate | ||||||
| Positive | 85 | 72 | 39 | 72 | 46 | 72 |
| Negative | 33 | 28 | 15 | 28 | 18 | 28 |
| Desmoplasia | ||||||
| Positive | 42 | 36 | 19 | 35 | 23 | 36 |
| Negative | 76 | 64 | 35 | 65 | 41 | 64 |
| Molecular subtype | ||||||
| Luminal A | 29 | 25 | 12 | 22 | 17 | 27 |
| Luminal B | 46 | 39 | 17 | 31 | 29 | 45 |
| Her2 | 25 | 21 | 16 | 30 | 9 | 14 |
| Triple negative | 18 | 24 | 9 | 17 | 9 | 14 |
Patients (n = 118), with invasive ductal breast cancer, were sorted in two groups based on presence/absence of metastasis in nearest ganglia. N0 = without metastasis in ganglia nodes. N1 = with at least one metastatic ganglia node.